1302 — LifeTech Scientific Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for LifeTech Scientific, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	925	1,097	1,267	1,304	1,370
Cost of Revenue
Gross Profit	748	874	996	981	1,019
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	597	729	884	1,117	1,185
Operating Profit	329	368	383	186	185
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	333	378	176	199	191
Provision for Income Taxes
Net Income After Taxes	283	319	107	168	112
Minority Interest
Net Income Before Extraordinary Items
Net Income	292	325	263	222	148
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	292	325	263	222	148
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.063	0.076	0.059	0.063	0.036